On November 24 2009 Gilead Sciences Inc and GlaxoSmithKline entered a licensing agreement to commercialise Viread(R) (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infe… more →
Silico Researchmatt1912 wrote 1 hour ago: Do you know someone who has the flu? Have you ever had the flu? If you answered “yes” to any of th … more →
silico wrote 1 week ago: On November 24 2009 Gilead Sciences Inc and GlaxoSmithKline entered a licensing agreement to commerc … more →
audaxinvestments wrote 1 month ago: One of the most impressive gains reported so far this quarter are those of Gilead Sciences (GiLD) . … more →
hotterthanapileofcurry wrote 1 month ago: As the H1N1 vaccination programme begins in earnest this week, I thought I’d share a few truth … more →
Kos wrote 4 months ago: Image by eagleglide via Flickr I had posted previously to watch out for a break out of a year-long t … more →
Jeremy G wrote 4 months ago: Two deals this week showcase collaborative efforts between major pharma players: Gilead Sciences … more →
untiltheresacure wrote 5 months ago: Two new online tools have been released this week, both in line with National HIV Testing Day on Jun … more →
lindsaymeyer wrote 6 months ago: On Wednesday afternoon, I returned my laptop, ID, and VPN token. I uninstalled TweetDeck, cleared m … more →
mrpace7 wrote 7 months ago: Tamiflu is an antiviral medication used to treat influenza. It will be the prime medication sold to … more →
thab00ger wrote 7 months ago: TB takes a swing at the swine flu… I’m guessing this could be a hoax but I don’t want to be ha … more →
pakalert wrote 7 months ago: by James Ridgeway Global Research, April 28, 2009 Mother Jones As the world gears up once again for … more →
Steve Woodruff wrote 8 months ago: Avastin approved for glioblastoma. Nice results for experimental blood pressure drug from Gilead - G … more →
Jeffrey Seguritan wrote 8 months ago: Last week unraveled a delirious splurge of M&A activity in the pharmaceutical industry, headline … more →
Jeremy G wrote 8 months ago: … Sold to the Knight in White for $1.4 billion? With Astellas announcing this morning that the … more →
Jeremy G wrote 8 months ago: Seems like $95 per share was the magic number for Genentech, which finally succumbed to Roche’ … more →
keggerss wrote 9 months ago: Well, that didn’t take long. After I knew President Obama was going to be our president, I ch … more →
keggerss wrote 10 months ago: I first wrote about Gilead (GILD) back in November in the mid $40s. It recently went over $52 per s … more →
ristikan wrote 1 year ago: Gilead Sciences remains an attractive takeover target for major drugmakers because of its promising … more →
Temple3 wrote 1 year ago: Would you? If so, why? If not, why not? Does anyone recall if Hillary wore a blue dress the first … more →